Supply Chain

While black people have one of the highest rates of type 2 diabetes in the country, this population is largely underrepresented in drug trials exploring new treatments for the condition, according to a new study published in The Lancet.

Deerfield, Ill.-based Takeda Pharmaceuticals entered into a definitive agreement to acquire Cambridge, Mass.-based ARIAD Pharmaceuticals at $24 per share for a total of $5.2 billion.

U.S. Sen. Amy Klobuchar (D-Minn.) is urging Teleflex Medical to take immediate action in correcting an issue with its nasal applicators for the opioid overdose drug naloxone, reports the StarTribune.

Here are the four latest drugs or medical devices approved by the Food and Drug Administration.

The Food and Drug Administration approved a new use for San Francisco-based Genentech's drug Lucentis.

Singapore-based Global Logistics Properties — the second largest warehouse operator in the world — is for sale, reports The Wall Street Journal.

Novartis has teamed up with Ionis Pharmaceuticals and its affiliate Akcea Therapeutics to license two experimental cardiovascular medications, reports Reuters.

SCM World released its fourth annual list of the top 100 universities for supply chain.

 Here are six articles published by Becker's Hospital Review in the past week that offer insight on the future of supply chain, controversial drugs and more.

Kalorama Information, a market research firm based in Rockville, Md., released a report detailing 10 trends that will likely affect the medical device industry in 2017.